Rebecca Brachman: A new class of drug that could prevent depression and PTSD
Rebecca Brachman: Un nuevo tipo de fármaco que podría prevenir la depresión y el TEPT
Rebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness. Full bio
Double-click the English transcript below to play the video.
were made from, of all things,
fueron elaborados, justamente,
sobró tras la Segunda Guerra Mundial.
one in five soldiers develop depression,
que hoy día uno de cada cinco soldados
por estrés postraumático o ambos.
that are at high risk for these diseases.
el riesgo de padecer estas enfermedades,
cancer patients, aid workers, refugees --
voluntarios, refugiados,
o estrés en exceso.
or major life stress.
these disorders are,
son muy comunes,
if they work at all,
cuando funcionan,
discovered the first vaccine --
descubrió la primera vacuna,
a prophylactic for a disease,
para la enfermedad,
de prevenir enfermedades.
to extend to psychiatric diseases.
psiquiátricas no eran prevenibles.
accidentally discovered
descubrimos por accidente
depression and PTSD.
prevenir la depresión y el TEPT.
experimentando con ratones
whether they work in humans.
si funcionan en seres humanos.
psychopharmaceuticals
no son antidepresivos,
la resiliencia al estrés,
stress resilience,
"potenciadores de la resiliencia".
that you've since recovered from.
de la que pudieron recuperarse,
you missed a flight.
haber perdido un vuelo...
is the active biological process
es el proceso biológico activo
to bounce back after stress.
recuperarnos tras el estrés.
and your immune system fights it off.
se deshace de un resfrío.
enough stressor,
una situación de estrés grave,
such as depression.
psiquiátrico como la depresión.
of major depressive disorder
depresivo se desencadenan por el estrés.
against purely biological stressors,
son capaces de proteger
como las hormonas del estrés,
psicológicos y sociales,
like bullying and isolation.
cuando dimos a los ratones
of stress hormones.
without a psychological component.
sin injerencia psicológica.
of antidepressant treatment beforehand,
con antidepresivos tres semanas antes,
enhancer given a week before
del potenciador de resiliencia
the depressive behavior.
depresivo por completo,
a drug has ever been shown
los efectos negativos del estrés.
often lifelong, clinical diseases.
por lo general, duran toda la vida.
of substance abuse, homelessness,
de abuso de sustancias, indigencia,
Alzheimer, suicidio...
is over three trillion dollars per year.
de dólares anuales.
where we know someone is predictively
pudiésemos predecir qué personas
to extreme stress.
estrés en exceso,
going into an earthquake zone.
que viaja a una zona de terremotos.
contra la fiebre tifoidea,
of a resilience enhancer
del potenciador de resiliencia
by looters or worse,
de criminales o algo peor,
against developing depression or PTSD
de desarrollar depresión y TEPT
from experiencing the stress,
le ocasione estrés,
her susceptibility to depression and PTSD,
a la depresión y al TEPT,
her home, her family or even her life.
su casa, su familia o incluso su vida.
the smallpox vaccine,
la vacuna contra la viruela,
vacunas con gran rapidez.
estuviera accesible para la mayoría.
was widely available.
pensaba que la tuberculosis
sensitive and creative and empathetic.
más sensible, creativa y empática
by constitution and not biology.
la complexión y no la biología.
today about depression.
respecto a la depresión.
opened the door
de Jenner abrió las puertas
that followed after,
que se desarrollaron luego,
abren las puertas a todo un nuevo campo:
open the possibility of a whole new field:
dentro de 15 o 150 años
choose to do with it.
decida hacer al respecto.
ABOUT THE SPEAKER
Rebecca Brachman - Neuroscientist, writer, entrepreneurRebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness.
Why you should listen
Current treatments for mood disorders only suppress symptoms without addressing the underlying disease, and there are no known cures. The drugs Rebecca Brachman is developing would be the first to prevent psychiatric disorders such as post-traumatic stress disorder (PTSD) and depression.
Brachman completed her PhD at Columbia University, prior to which she was a fellow at the National Institutes of Health, where she discovered that immune cells carry a memory of psychological stress and that white blood cells can act as antidepressants and resilience-enhancers. Brachman's research has been featured in The Atlantic, WIRED and Business Insider, and her work was recently described by Dr. George Slavich on NPR as a "moonshot project that is very much needed in the mental health arena."
In addition to conducting ongoing research at Columbia, Brachman is an NYCEDC Entrepreneurship Lab Fellow and cofounder of Paravax -- a biotech startup developing vaccine-like prophylactic drugs ("paravaccines") -- along with her scientific collaborator, Christine Ann Denny. She is also working on a non-profit venture to repurpose existing generic drugs for use as prophylactics, and previously served as the Interim Program Director for Outreach at the Zuckerman Institute at Columbia University.
Brachman is also a playwright and screenwriter. She holds Bachelor's degrees in both neuroscience and creative wWriting, and she is currently working on a tech-focused writing project with her long-time writing partner, Sean Calder ("Grimm," "Damages," "ER"). She served as the director of NeuWrite, a national network of science-writing groups that fosters ongoing collaboration between scientists, writers and artists, and she has been featured as a storyteller at The Story Collider.
(Photo: Kenneth Willardt)
Rebecca Brachman | Speaker | TED.com